https://www.selleckchem.com/pr....oducts/capsazepine.h
We investigated the relationship between glucose variability and frailty. Forty-eight type 2 diabetic patients aged ≥ 65 years were enrolled. The FRAIL scale was used for frailty assessment, and participants were classified into 'healthy pre-frail' (n = 24) and 'frail' (n = 24) groups. A continuous glucose monitoring (CGM) system was used for a mean of 6.9 days and standardized CGM metrics were analyzed mean glucose, glucose management indicator (GMI), coefficient of variation, and time in range, time above range (TAR), and ti
Like
Comment
Share
